ABIGAIL BRIGHT: Open Payments
NPI 1528755543 · MECHANICSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 25 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $442 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| PFIZER INC. | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $65 |
| GENZYME CORPORATION | 2 | $59 |
| ABBVIE INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, DUPIXENT, XELJANZ, VELSIPITY, VOQUEZNA, IQIRVO.
Industry payments across VA — which companies pay providers there.
